Companion Diagnostics for Immune Oncology with Episwitch® & 3D Genomics
Time: 4:00 pm
day: Day Three PM
Details:
• PD-(L)1 Checkpoint Inhibitors – Relevant Predictive & Prognostic Assays
• Targeted qPCR versus multi-variate assays on Agilent arrays
• EpiSwitch Data Knowledge: Prognosis for prevention of immune-related adverse events (irAE's)
